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  A case of nontraumatic renal subcapsular hematoma was reported．
  The patient was 67－year－old i・voman， who complained of the left flank colic pain and
macroscopic hematuria without any history of the left flank injury． Ultrasonography demons－
tratedユeft renal solid mass． Excretory pyelography de皿onstrated a large mass involving
the left kidney with medial・ dkplacement of collecting’ systern． Retrograde pyelography
confirmed the presence of a left renal mass with pressure on the pelvis and calyces． A
renal arteriography revealed flattening of the lateral border of the left kidney and failed to
demonstrate either tumor vasculature or evidence of vascular disease．
  Left nephrectomy was performed and the removed kidney weighed 118 g， sized IO．5×6．0
×5． 5 cm． Left renal subcapsular hematoma was confirmed with no bleeding in the perinephric






























34mm（1時聞値）， RBC 369×104／mm3 WBC 62
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Fig． 1． Urogram demonstrates a large mass
    involving the left kidney with medial







Fig． 2．Ultrasonography demonstrates left
renal solid mass．
Fig． 3． Retrograde pyelogram confirms the
   presence of a left renal mass with













Fig． 4． Renal arteriogram demonstrates displa－
    cement of renal vessels without evidence
    of tumor vasculature and nephrographic
    phase shows flattening of kidney．
Fig． 5． Removed kidney shows subcapsular hem－
    atoma without any evidence of tumor
    or infarction in the renal parenchyma．
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Fig． 6． Microscopic section confirms organiz－














































Table 1． Roentogenographic features of
     subcapsular hematoma．
1． Outline of kidney and retroperitoneal struct－
  ures usually preserved
2． Renal silhouette is enlarged but maintains
  reniform configuration
3． Collecting system usually displaced media－
  11y， and is disproportionately smaller than
  renal silhouette．
4． Flattening of renal surface beneath hemato－
  ma
5． Visualization of elevated renal capsule （se－
  en on tomography ＆ angiography）
6． Capsular arteries may be displaced but ma－
  intain normal close relationship to capsule
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フトラフールズポ・ズポS
3つの吸収経路
1．フトラフールは主に肝臓で活性化され、活性物質である5－FU、FUR、
 FUMPの濃度が長時間持続します。この長時間持続性は代謝拮抗剤
 による癌化学療法において極めて重要なことです。
2．フトラフールはmasked compoundのため、副作用が軽微で、長期連続
 投与が可能です。
3．初回治療にも非初回治療にも有効であり、癌化学療法における寛
 解導入のみならず、寛解強化療法、寛解維持療法として使用され
 特に病理組織学的に腺癌と診断された症例に有効です。
◎翻島蕪曇鷺灘三三
